BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
©The Author(s) 2025.
World J Orthop. Oct 18, 2025; 16(10): 111955
Published online Oct 18, 2025. doi: 10.5312/wjo.v16.i10.111955
Table 3 Treatment details, n (%)
Variables
Group A
Group B
P value
First-stage surgeryn = 39n = 59
ETO12 (35) 19 (41)0.38
Gentamicin beads6 (15) 0 (0) 0.07
Mean surgical time, min (SD) 149 (49.4)179 (60.0) 0.02
Mean blood loss, mL (SD)1128 (581.6) 984 (531.5) 0.32
Interval weightbearing allowance1< 0.001
    0%32 (82) 21 (36)
    10%7 (18) 29 (49)
    50%0 (0) 9 (15)
Mean length of hospital stay, days (SD)16 (8.3) 9 (6.5) < 0.001
Discharge destination 0.048
Home9 (26) 28 (48)
Extended care facility26 (74) 30 (52)
Second-stage surgeryn = 35n = 58
Mean interval duration, days (SD) 213 (266.3) 110 (113.9) 0.01
Mean surgical time, min (SD)157 (40.1) 165 (54.7) 0.51
Mean blood loss, mL (SD)1042 (710.1) 886 (586.0) 0.36
Postoperative weightbearing allowance10.71
    0%0 (0) 2 (4)
    10%3 (9) 5 (9)
    50%14 (40) 23 (41)
    100 18 (51) 26 (46)
Mean length of hospital stay, days (SD)10 (10.9) 8 (5.6) 0.16
Discharge destination 0.83
Home 20 (61) 31 (57)
Extended care facility13 (39) 23 (43)


Write to the Help Desk